The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1, open-label, multi-center trial of RPT1G in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syndromes/neoplasms.
 
Dennise De Jesus Diaz
Employment - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - Remedy Plan Therapeutics
 
Aaron Goldberg
Honoraria - Dava Oncology; OncLive/MJH Life Sciences
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bristol-Myers Squibb/Celgene; Cardinal Health; Ikena Oncology; IntrinsiQ; Kura Oncology; Mitsubishi Tanabe Pharma; Molecular Partners; Pfizer; Remedy Plan Therapeutics; Syndax; Systimmune
Research Funding - Abbvie (Inst); Aprea Therapeutics (Inst); Aptose Biosciences (Inst); Arog (Inst); GlaxoSmithKline (Inst); Kura Oncology (Inst); Pfizer (Inst); Prelude Therapeutics (Inst); Remedy Plan Therapeutics (Inst)
Travel, Accommodations, Expenses - Kura Oncology; Molecular Partners
 
Steve Abella
Consulting or Advisory Role - Remedy Plan Therapeutics; Shasqi Inc.
 
Caroline Robb
Employment - Remedy Plan, Inc.
Patents, Royalties, Other Intellectual Property - Remedy Plan, Inc. patent (Inst)
Travel, Accommodations, Expenses - Remedy Plan, Inc.
 
Michael Schelle
Employment - Remedy Plan Therapeutics
 
Gregory Crimmins
Employment - Remedy Plan Therapeutics
Leadership - Remedy Plan Therapeutics
Stock and Other Ownership Interests - Remedy Plan Therapeutics
Patents, Royalties, Other Intellectual Property - Remedy Plan Therapeutics